banner
Pawg khoom
Tiv tauj peb

Hu rau:Errol Zhou (Mr.)

Tel: ntxiv 86-551-65523315

Mobile/WhatsApp: ntxiv 86 17705606359

QQ:196299583

Skype:lucytoday@hotmail.com

Email:sales@homesunshinepharma.com

Ntxiv:1002, Huanmao Tsev, No.105, Mengcheng Txoj kev, Hefei Lub zos, 230061 Tuam Tshoj

APIs thiab Intermediates
1-(3-Methoxyphenyl)piperazine Dihydrochloride CAS 16015-70-6

1-(3-Methoxyphenyl)piperazine Dihydrochloride CAS 16015-70-6

CAS Nr: 16015-70-6
Cov mis mos molecular: C11H17ClN2O
Molecular Luj: 228.72
EINECS NO: N / A
MDL Nr.: MFCD08448702

Txhawb tshuaj

Product Description:

Lub npe khoom: 1-(3-Methoxyphenyl)piperazine dihydrochloride CAS 16015-70-6

 

Synonyms:

Piperazine, 1-(3-Methoxyphenyl)-, Monohydrochloride;

Piperazine, 1-(3-methoxyphenyl)-, hydrochloride;

 

Chemical & Physical Properties

Cov tsos mob: Dawb los yog tawm-dawb crystalline hmoov

Kev Ntsuas: 99% +

 

Daim ntawv thov

(3-methoxyphenyl) piperazine hydrochloride yog ib qho heterocyclic derivative thiab siv tau los ua ib qho nruab nrab hauv cov organic synthesis.Nws yog ib qho nruab nrab ntawm Lettermovir.Letremovir, ib qho tshuaj tshiab tsim los ntawm Merck Pharmaceuticals rau kev kho mob ntawm cov neeg laus cov neeg mob uas muaj seropositive. rau cytomegalovirus (CMV) tom qab allogeneic hematopoietic qia cell transplantation (HSCT), tau pom zoo los ntawm US FDA thaum lub Kaum Ib Hlis 9, 2017 nyob rau hauv lub npe lag luam Prevymis.

 

 

Yog tias koj txaus siab rau peb cov khoom lossis muaj lus nug, thov koj xav tiv tauj peb!

 

Cov khoom raws li patent yog muab rau R & D lub hom phiaj nkaus xwb. Txawm li cas los xij, lub luag haujlwm kawg tsuas yog nrog tus neeg yuav khoom.

Cim npe nrov: 1-(3-methoxyphenyl)piperazine dihydrochloride cas 16015-70-6, tuam ntxhab, lwm tus muag khoom, Hoobkas, yuav, hauv Tshuag

Xa kev nug